We first investigated how the two types of data, tumor-derived transcriptomes and NAT-derived transcriptomes, transcriptionally differentiate RC from nonRC states with respect to the numbers and the statistical significance of DEGs. The gene discussed is BRD2; the disease is neoplasm.